keyword
Keywords adverse reactions corticostero...

adverse reactions corticosteroid injections

https://read.qxmd.com/read/38634160/effect-of-minoxidil-combined-with-triamcinolone-acetonide-on-alopecia-areata-by-microneedle-injection
#1
JOURNAL ARTICLE
Fanglin Wei, Cui Cheng Jun, Shasha Cheng, Ling Fang
OBJECTIVE: Alopecia areata (AA) is often characterized by sudden onset of patchy hair loss. Topical corticosteroid injection is the most common treatment. This study retrospectively observed the clinical efficacy of microneedle minoxidil combined with triamcinolone acetonide in the treatment of AA. METHODS: A total of 230 patients with AA were selected. The experimental group (n = 120) received physician training and home microneedle treatment with minoxidil combined with triamcinolone acetonide once a week...
April 2024: Skin Research and Technology
https://read.qxmd.com/read/38533255/editorial-research-challenges-of-drug-utilization-data-collection-data-validation-and-adverse-drug-reactions-in-neonates
#2
EDITORIAL
Robert M Ward
No abstract text is available yet for this article.
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38489062/safety-of-biological-therapies-for-severe-asthma-an-analysis-of-suspected-adverse-reactions-reported-in-the-who-pharmacovigilance-database
#3
JOURNAL ARTICLE
Paola Maria Cutroneo, Elena Arzenton, Fabiana Furci, Fabio Scapini, Maria Bulzomì, Nicoletta Luxi, Marco Caminati, Gianenrico Senna, Ugo Moretti, Gianluca Trifirò
BACKGROUND: The management of uncontrolled severe asthma has greatly improved since the advent of novel biologic therapies. Up to August 2022, five biologics have been approved for the type 2 asthma phenotype: anti-IgE (omalizumab), anti-IL5 (mepolizumab, reslizumab, benralizumab), and anti-IL4 (dupilumab) monoclonal antibodies. These drugs are usually well tolerated, although long-term safety information is limited, and some adverse events have not yet been fully characterized. Spontaneous reporting systems represent the cornerstone for the detection of potential signals and evaluation of the real-world safety of all marketed drugs...
March 15, 2024: BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
https://read.qxmd.com/read/38454591/drug-induced-stevens-johnson-syndrome-in-post-traumatic-facial-injury
#4
JOURNAL ARTICLE
Asfiya Samar, G N Sahana, P Deepak, Jayashree V Nagaral, M Saranyaa
Stevens-Johnson syndrome is a severe adverse drug reaction affecting the skin and mucous membrane. The causes include Sulfonamides, Anticonvulsants, etc. A patient developed ulcerations in the lips and oral cavity with difficulty in swallowing and rashes over the back, abdomen, and genitalia following administration of injection ceftriaxone 1 g intravenous (IV) b.i.d, injection pantoprazole 40 mg IV b.i.d, tablet aceclofenac + paracetamol 325 mg b.i.d, tablet cetirizine 10 mg b.i.d, chlorhexidine mouth wash, and injection metronidazole 500 mg IV t...
January 1, 2024: Indian Journal of Pharmacology
https://read.qxmd.com/read/38334217/treatments-for-morton-s-neuroma
#5
REVIEW
Barry G Matthews, Colin E Thomson, Michael P Harding, John C McKinley, Robert S Ware
BACKGROUND: Morton's neuroma (MN) is a painful neuropathy resulting from a benign enlargement of the common plantar digital nerve that occurs commonly in the third webspace and, less often, in the second webspace of the foot. Symptoms include burning or shooting pain in the webspace that extends to the toes, or the sensation of walking on a pebble. These impact on weight-bearing activities and quality of life. OBJECTIVES: To assess the benefits and harms of interventions for MN...
February 9, 2024: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/38199911/monocentric-study-of-il-5-monoclonal-antibody-induction-therapy-for-eosinophilic-granulomatosis-with-polyangiitis
#6
JOURNAL ARTICLE
Chrong-Reen Wang, Hung-Wen Tsai, Chi-Chang Shieh
OBJECTIVE: Although sporadic case reports have demonstrated successful management of eosinophilic granulomatosis with polyangiitis (EGPA) by anti-IL-5 therapy, larger-scale monocentric studies for the efficacy of mepolizumab (MEP), an IL-5 monoclonal antibody, are still lacking in Taiwan. METHODS: Hospitalized EGPA patients aged at least 18 years were enrolled from November 1998 to October 2023, and analyzed for demographic, clinical, laboratory, medication and outcome data, focusing on the efficacy and safety of biologics use, particularly induction therapy with MEP...
January 9, 2024: Journal of the Formosan Medical Association
https://read.qxmd.com/read/38161516/bilateral-punctate-keratitis-and-hurricane-keratopathy-following-apremilast-therapy
#7
Logan Wolfel, Jimena Franco, Thomas Bradford Gillette, James Chodosh, Alexander Davis
PURPOSE: To report a unique case of bilateral punctate keratitis consistent with hurricane keratopathy during apremilast therapy. OBSERVATIONS: A 49-year-old female presented with severe, painful, bilateral, punctate keratitis following five months of apremilast therapy. The past ocular history was noncontributory. The past medical history included psoriasis refractory to topical corticosteroids. The patient subsequently received systemic apremilast therapy and noted improvement in her psoriatic rash...
December 2023: American Journal of Ophthalmology Case Reports
https://read.qxmd.com/read/38125343/toxic-epidermal-necrolysis-after-injection-of-sclerosing-agent-and-medical-adhesive-into-oesophageal-variceal-ligation-in-a-patient-with-a-malignant-liver-tumour-a-case-report
#8
Liangchao Hao, Wei Cai, Zhaomu Zeng, Xiuchao Geng, Qiang Li, Hong Chen, Yuhao Zhang, Juan Ding
Chronic liver disease can cause an increase in portal sinus pressure, which may lead to rupture and bleeding of esophageal and gastric varices. Oesophageal variceal ligation, with use of sclerosing agent and tissue glue injection is commonly used in clinical practice to address oesophageal bleeding. A 58-year-old male patient with chronic liver disease was treated with oesophageal variceal ligation, sclerosing agent and tissue glue injection due to oesophageal and gastric variceal bleeding. After 2 days, the skin of the patient exhibited erythema to different degrees...
January 2024: Experimental and Therapeutic Medicine
https://read.qxmd.com/read/38088944/a-pilot-study-on-tocilizumab-in-very-late-onset-myasthenia-gravis
#9
JOURNAL ARTICLE
Ting-Ting Yang, Ze-Yi Wang, Ze-Xin Fan, Bo-Yi Yuan, Lin Ma, Jian-Feng Lu, Pen-Ju Liu, Yang He, Guang-Zhi Liu
OBJECTIVE: This study aimed to initially investigate the efficacy and safety of low-dose tocilizumab combined with glucocorticoid for the treatment of very-late-onset myasthenia gravis (VLOMG). METHODS: We conducted a retrospective study in VLOMG patients who were administered intravenous methylprednisolone therapy and subsequently received low-dose oral corticosteroid, in combination with intravenous injection of tocilizumab given once every month for three months...
2023: Journal of Inflammation Research
https://read.qxmd.com/read/37979147/severe-contour-deformity-of-the-hip-following-corticosteroid-injection
#10
JOURNAL ARTICLE
Lawrence J Lin, Tiffany X Chen, Laith M Jazrawi, Ernest S Chiu
A 50-year-old woman developed severe soft tissue atrophy of the hip following a triamincolone acetonide injection to the greater trochanteric bursa. Saline injection therapy was initially attempted without improvement and the defect was ultimately treated effectively with serial fat grafting. Adverse soft tissue reactions are rare but potentially devastating complications of corticosteroid injections, and the use of soluble steroid preparations and proper injection techniques can minimize the risk to surrounding tissue...
December 2023: Bulletin of the Hospital for Joint Diseases
https://read.qxmd.com/read/37734750/omalizumab-for-chinese-patients-with-moderate-to-severe-allergic-asthma-in-real-world-clinical-setting-a-prospective-observational-study
#11
JOURNAL ARTICLE
Wen Wang, Jieying Li, Congying Zou, Lifang Zhao, Ya Zhu, Yue Guo, Feiran Wang
BACKGROUND: We aimed to investigate the effectiveness of omalizumab, a monoclonal anti-immunoglobulin E antibody, in Chinese patients with moderate-to-severe allergic asthma in real-world clinical practice. METHODS: This single-centre, prospective, observational study included Chinese patients aged 14-75 years with moderate-to-severe allergic asthma according to the Global Initiative for Asthma criteria. Omalizumab was administered subcutaneously, and the investigator collected real-world data on exacerbations, steroid exposure, pulmonary function and laboratory assessments at weeks 16, 24, 52, 104 and 156 after treatment initiation...
September 2023: BMJ Open Respiratory Research
https://read.qxmd.com/read/37655266/recalcitrant-nodular-scabies-showing-excellent-response-to-tofacitinib-five-case-reports
#12
Yu-Kun Zhao, Jing-Fa Lu, Juan-Hua Liu, Hui-Hui Wu, Lu-Li Song, Chun-Lei Wan, Di-Qing Luo
Scabies is a contagious skin condition caused by Sarcoptes scabiei , and it is always associated with an intense, unbearable, nocturnal deteriorating itch. Its presentations include classic burrows, erythema, pruritic papules, pustules, vesicles, and inflammatory nodules, with diffuse or localized distribution on the finger webs, wrist flexors, elbows, axillae, buttocks, genitalia, and breasts. Nodular scabies is an uncommon clinical variant of scabies. Its management is still challenging for some patients up to date, although topical, intralesional or systemic corticosteroids, topical calcineurin inhibitors, and crotamiton as well as cryotherapy alone or in different combinations are used...
2023: Therapeutic Advances in Chronic Disease
https://read.qxmd.com/read/37535976/musculoskeletal-corticosteroid-injection-and-risk-of-acute-coronary-syndrome-a-case-control-study
#13
JOURNAL ARTICLE
Katharine Thomas, Yochai Schonmann
BACKGROUND: Musculoskeletal corticosteroid injection (CSI) is a frequently used treatment, considered safe with a low incidence of minor side effects. OBJECTIVE: To investigate whether the incidence of acute coronary syndrome (ACS) is increased following corticosteroid injection for musculoskeletal conditions. METHODS: Data were reviewed from 41,276 patients aged over 40 years and hospitalised with ACS between January 2015 and December 2019...
November 23, 2023: Family Practice
https://read.qxmd.com/read/37499774/enhanced-powder-dispersion-of-dual-excipient-spray-dried-powder-formulations-of-a-monoclonal-antibody-and-its-fragment-for-local-treatment-of-severe-asthma
#14
JOURNAL ARTICLE
Harry W Pan, Jinlin Guo, Lingqiao Zhu, Susan W S Leung, Chenghai Zhang, Jenny K W Lam
The advent of biologics has brought renewed hope for patients with severe asthma, a condition notorious for being hampered by poor response to conventional therapies and adverse drug reactions owing to corticosteroid dependence. However, biologics are administered as injections, thereby precluding the benefits inhalation therapy could offer such as increased bioavailability at the site of action, minimal systemic side effects, non-invasiveness, and self-administration. Here, 2-hydroxypropyl-beta-cyclodextrin and ʟ-leucine were co-spray-dried, as protein stabiliser and dispersion enhancer, respectively, at various weight ratios to produce a series of formulation platforms...
July 25, 2023: International Journal of Pharmaceutics
https://read.qxmd.com/read/37451616/-blue-wheals-and-blue-angioedema-induced-by-blue-dyes-a-systematic-review
#15
JOURNAL ARTICLE
Kanokvalai Kulthanan, Papapit Tuchinda, Sasima Eimpunth, Suebwong Chuthapisith, Pranee Rushatamukayanunt, Pichaya Limphoka, Waratchaya Panjapakkul, Oraya Pochanapan, Marcus Maurer
BACKGROUND: "Blue wheals" and "blue angioedema", the adverse reactions to blue-dye injections with or without anaphylaxis, are poorly defined. OBJECTIVE: The objective is to review the characteristics (i.e., sex and age at onset, interval between blue dye injection and symptom onset, clinical manifestations, duration of blue wheals or angioedema), natural courses, and treatments of blue-dye adverse reactions. METHODS: A review of the articles published through July 2021 was performed per the Preferred Reporting Items for Systematic Reviews and Meta-Analysis recommendations...
July 12, 2023: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/37440972/nicolau-syndrome-associated-with-fluphenazine-depot-a-case-report
#16
Soumitra Das, Vallabh Shet, Thusanth Jogarajah, Abdulgafar Ibrahim, Marlon Reyes, Elaiza Marie Fernandez Co, Balaswamy Reddy
Nicolau syndrome is a rare condition characterized by severe pain at the site of injection, leading to ulceration and necrosis of the local tissues. Its presentation is usually acute. Nicolau syndrome is commonly seen in patients after intramuscular, intra-articular, or subcutaneous injections of non-steroidal anti-inflammatory drugs, antiepileptics, antipsychotics, antibiotics, antihistamines, and corticosteroids. Immediate diagnosis and management of this syndrome are of great importance. We herein report a rare presentation of Nicolau syndrome in a 36-year-old married male who suffered from paranoid schizophrenia for the past 3 years...
2023: SAGE Open Medical Case Reports
https://read.qxmd.com/read/37283625/development-of-bullous-pemphigoid-during-treatment-of-psoriasis-with-ustekinumab-a-case-report-and-literature-review
#17
Luyang Kong, Dawei Huang, Jiajing Lu, Yuexin Zhang, Ying Li, Xuemei Yi, Yuling Shi
Ustekinumab is a biological therapy that has been approved for treating moderate-to-severe psoriasis. Although injection site reactions, nasopharyngitis, headaches, and infections are the common adverse events associated with ustekinumab, the development of bullous pemphigoid (BP) is also thought to be related to ustekinumab. Given that psoriasis itself can be complicated by BP, it is worthwhile to investigate the relationship between ustekinumab, psoriasis, and BP. Here we report a case of a male patient who developed BP twice after psoriasis treatment with ustekinumab...
2023: Frontiers in Medicine
https://read.qxmd.com/read/37157992/hesitancy-reactogenicity-and-immunogenicity-of-the-mrna-and-whole-virus-inactivated-covid-19-vaccines-in-pediatric-neuromuscular-diseases
#18
JOURNAL ARTICLE
Michael Kwan Leung Yu, Sophelia Hoi Shan Chan, Samuel Cheng, Daniel Leung, Sau Man Chan, Amy Suen Ka Yan, Wilfred Hing Sang Wong, Malik Peiris, Yu Lung Lau, Jaime S Rosa Duque
The mRNA-based BNT162b2 and inactivated whole-virus CoronaVac are two widely used COVID-19 vaccines that confer immune protection to healthy individuals. However, hesitancy toward COVID-19 vaccination appeared to be common for patients with neuromuscular diseases (NMDs) due to the paucity of data on the safety and efficacy in this high-risk patient population. Therefore, we examined the underlying factors associated with vaccine hesitancy across time for NMDs and assessed the reactogenicity and immunogenicity of these two vaccines...
May 9, 2023: Human Vaccines & Immunotherapeutics
https://read.qxmd.com/read/37077055/localised-swelling-at-sites-of-dermal-filler-injections-following-administration-of-covid-19-vaccines-a-systematic-review
#19
REVIEW
Chew Lip Ng, Evelyn Yuxin Tay, Alwyn Ray D'Souza
INTRODUCTION: Localised swelling at sites of filler injections has been reported in the Moderna mRNA-1273 coronavirus disease 2019 (COVID-19) vaccine trial. METHODS: We conducted a review of the existing data and literature on the potential pathophysiology for this adverse event and its potential management. RESULTS: Data from the Moderna and Pfizer COVID-19 vaccine Phase 3 trial and one case series were available. Three out of 30,400 subjects developed possible filler reaction in the Moderna trial...
April 13, 2023: Singapore Medical Journal
https://read.qxmd.com/read/36892711/outcomes-of-intraarticular-triamcinolone-acetonide-injection-in-children-with-non-systemic-juvenile-idiopathic-arthritis
#20
JOURNAL ARTICLE
Maynart Sukharomana, Sirirat Charuvanij
OBJECTIVES: The objectives were to explore the response to intraarticular triamcinolone acetonide (TA) injection in children with non-systemic juvenile idiopathic arthritis (JIA) and factors associated with time to arthritis flare. METHODS: This was a retrospective cohort study of children with non-systemic JIA who received intraarticular TA injections at a tertiary care hospital in Bangkok, Thailand. Response to intraarticular TA injection was defined as absence of arthritis at 6 months after procedure...
March 9, 2023: Clinical Rheumatology
keyword
keyword
76651
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.